Emergent BioSolutions (EBS) Net Cash Flow (2010 - 2026)
Emergent BioSolutions (EBS) posted Net Cash Flow of -$20.6 million for Q2 2026, up 56.72% on a QoQ basis from -$47.6 million in Q1 2026, and down 117.58% year-over-year from $117.2 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Net Cash Flow (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Net Cash Flow for 17 years, with the latest figure at -$20.6 million in Q2 2026.
- On a quarterly basis, Net Cash Flow fell 117.58% year-over-year to -$20.6 million in Q2 2026; TTM through Jun 2026 was -$129.9 million, a 165.05% decrease from a year earlier, with the FY2025 full-year figure at $103.4 million, up 1795.08% from the prior year.
- Net Cash Flow was -$20.6 million for Q2 2026 at Emergent BioSolutions, up from -$47.6 million in the prior quarter.
- The five-year high for Net Cash Flow was $400.5 million in Q4 2022, with the low at -$343.6 million in Q2 2023.
- Average Net Cash Flow over 5 years is -$24.2 million, with a median of -$27.2 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Net Cash Flow plunged 338.27% in 2023, then jumped 4594.74% in 2024.
- Over 5 years, Net Cash Flow stood at $400.5 million in 2022, then plunged by 93.66% to $25.4 million in 2023, then slumped by 300.0% to -$50.8 million in 2024, then rose by 21.06% to -$40.1 million in 2025, then jumped by 48.63% to -$20.6 million in 2026.
- The last three Net Cash Flow figures came in at -$20.6 million (Q2 2026), -$47.6 million (Q1 2026), and -$40.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | -722.00 Mn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | -851.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 918.27 Mn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 407.41 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 374.50 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | -20.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.60 Mn |
| Mar 31, 2026 | -47.60 Mn |
| Dec 31, 2025 | -40.10 Mn |
| Sep 30, 2025 | -21.60 Mn |
| Jun 30, 2025 | 117.20 Mn |
| Mar 31, 2025 | 47.90 Mn |
| Dec 31, 2024 | -50.80 Mn |
| Sep 30, 2024 | 85.40 Mn |
| Jun 30, 2024 | -8.00 Mn |
| Mar 31, 2024 | -32.70 Mn |
| Dec 31, 2023 | 25.40 Mn |
| Sep 30, 2023 | -1.90 Mn |
| Jun 30, 2023 | -343.60 Mn |
| Mar 31, 2023 | -209.60 Mn |
| Dec 31, 2022 | 400.50 Mn |
| Sep 30, 2022 | -116.30 Mn |
| Jun 30, 2022 | -78.40 Mn |
| Mar 31, 2022 | -140.00 Mn |
| Dec 31, 2021 | 172.30 Mn |
| Sep 30, 2021 | -43.50 Mn |
API Access
Emergent BioSolutions Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();